Literature DB >> 9585525

Calf spleen purine nucleoside phosphorylase complexed with substrates and substrate analogues.

C Mao1, W J Cook, M Zhou, A A Federov, S C Almo, S E Ealick.   

Abstract

Purine nucleoside phosphorylase (PNP) is a key enzyme in the purine salvage pathway, which provides an alternative to the de novo pathway for the biosynthesis of purine nucleotides. PNP catalyzes the reversible phosphorolysis of 2'-deoxypurine ribonucleosides to the free bases and 2-deoxyribose 1-phosphate. Absence of PNP activity in humans is associated with specific T-cell immune suppression. Its key role in these two processes has made PNP an important drug design target. We have investigated the structural details of the PNP-catalyzed reaction by determining the structures of bovine PNP complexes with various substrates and substrate analogues. The preparation of phosphate-free crystals of PNP has allowed us to analyze several novel complexes, including the ternary complex of PNP, purine base, and ribose 1-phosphate and of the completely unbound PNP. These results provide an atomic view for the catalytic mechanism for PNP proposed by M. D. Erion et al. [(1997) Biochemistry 36, 11735-11748], in which an oxocarbenium intermediate is stabilized by phosphate and the negative charge on the purine base is stabilized by active site residues. The bovine PNP structure reveals several new details of substrate and inhibitor binding, including two phosphate-induced conformational changes involving residues 33-36 and 56-69 and a previously undetected role for His64 in phosphate binding. In addition, a well-ordered water molecule is found in the PNP active site when purine base or nucleoside is also present. In contrast to human PNP, only one phosphate binding site was observed. Although binary complexes were observed for nucleoside, purine base, or phosphate, ribose 1-phosphate binding occurs only in the presence of purine base.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9585525     DOI: 10.1021/bi9723919

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  18 in total

1.  The consequences of translational and rotational entropy lost by small molecules on binding to proteins.

Authors:  Christopher W Murray; Marcel L Verdonk
Journal:  J Comput Aided Mol Des       Date:  2002-10       Impact factor: 3.686

2.  Altered enthalpy-entropy compensation in picomolar transition state analogues of human purine nucleoside phosphorylase.

Authors:  Achelle A Edwards; Jennifer M Mason; Keith Clinch; Peter C Tyler; Gary B Evans; Vern L Schramm
Journal:  Biochemistry       Date:  2009-06-16       Impact factor: 3.162

3.  Preliminary crystallographic studies of purine nucleoside phosphorylase from the cariogenic pathogen Streptococcus mutans.

Authors:  Qiao Ming Hou; Xiang Liu; Erik Brostromer; Lan Fen Li; Xiao Dong Su
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2009-11-27

4.  Glycal formation in crystals of uridine phosphorylase.

Authors:  Debamita Paul; Seán E O'Leary; Kanagalaghatta Rajashankar; Weiming Bu; Angela Toms; Ethan C Settembre; Jennie M Sanders; Tadhg P Begley; Steven E Ealick
Journal:  Biochemistry       Date:  2010-04-27       Impact factor: 3.162

5.  YLR209c encodes Saccharomyces cerevisiae purine nucleoside phosphorylase.

Authors:  K Lecoq; I Belloc; C Desgranges; M Konrad; B Daignan-Fornier
Journal:  J Bacteriol       Date:  2001-08       Impact factor: 3.490

Review 6.  Structural analyses reveal two distinct families of nucleoside phosphorylases.

Authors:  Matthew J Pugmire; Steven E Ealick
Journal:  Biochem J       Date:  2002-01-01       Impact factor: 3.857

7.  Design of an adenosine phosphorylase by active-site modification of murine purine nucleoside phosphorylase. Enzyme kinetics and molecular dynamics simulation of Asn-243 and Lys-244 substitutions of purine nucleoside phosphorylase.

Authors:  J T Maynes; W Yam; J P Jenuth; R Gang Yuan; S A Litster; B M Phipps; F F Snyder
Journal:  Biochem J       Date:  1999-12-01       Impact factor: 3.857

8.  Immucillin-H binding to purine nucleoside phosphorylase reduces dynamic solvent exchange.

Authors:  F Wang; R W Miles; G Kicska; E Nieves; V L Schramm; R H Angeletti
Journal:  Protein Sci       Date:  2000-09       Impact factor: 6.725

9.  Humanized ADEPT comprised of an engineered human purine nucleoside phosphorylase and a tumor targeting peptide for treatment of cancer.

Authors:  Sepideh Afshar; Tsuneaki Asai; Sherie L Morrison
Journal:  Mol Cancer Ther       Date:  2009-01       Impact factor: 6.261

10.  Cloning, purification and characterisation of a recombinant purine nucleoside phosphorylase from Bacillus halodurans Alk36.

Authors:  Daniel F Visser; Fritha Hennessy; Konanani Rashamuse; Maureen E Louw; Dean Brady
Journal:  Extremophiles       Date:  2010-03       Impact factor: 2.395

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.